Literature DB >> 9918203

Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy.

G D Carystinos1, M M Katabi, D W Laird, J Galipeau, H Chan, M A Alaoui-Jamali, G Batist.   

Abstract

The phenomenon of the "bystander effect" (BE) observed in suicide gene therapy studies leads to the intriguing possibility that cytotoxicity can be achieved even in tumor cells that have not themselves been targeted with novel genetic material. There is considerable data suggesting the role of gap junction-mediated intercellular communication (GJIC) in the BE. Transfer of connexin (Cx)-encoding genes, the building blocks of GJIC, has been shown both in vitro and in vivo to increase the BE. Since the loss of GJIC is a common feature of cancer cells, we examined the consequence of GJIC up-regulation on the BE in suicide gene therapy. We used 8-bromo-cyclic-AMP to induce Cx43 and GJIC. In mixing assays, using various proportions of cells containing viral thymidine kinase delivered by an adenoviral delivery system or stably transduced by a retrovirus vector, 8-bromo-cyclic-AMP enhanced the BE of cell killing using ganciclovir. The induction in cell killing was more significant when a low percentage of the cell population was infected, which is the relevant clinical situation. We have demonstrated that this is not due to an effect on infectivity or suicide gene expression. Since decreased GJIC is part of the transformed phenotype, induction of Cxs provides an element of selectivity to suicide gene therapy. Our study adds strength to the rationale to develop clinically tolerable GJ inducers to potentiate the effect of suicide gene therapy via the BE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918203

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  8 in total

Review 1.  Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.

Authors:  Andressa Ardiani; Adam J Johnson; Hongmei Ruan; Marilyn Sanchez-Bonilla; Kinta Serve; Margaret E Black
Journal:  Curr Gene Ther       Date:  2012-04-01       Impact factor: 4.391

2.  Bystander effects and compartmental stress response to X-ray irradiation in L929 cells.

Authors:  Mihaela Temelie; Daniela Stroe; Ileana Petcu; Cosmin Mustaciosu; Nicoleta Moisoi; Diana Savu
Journal:  Radiat Environ Biophys       Date:  2016-03-30       Impact factor: 1.925

3.  Connexin mediates gap junction-independent resistance to cellular injury.

Authors:  Jane H-C Lin; Jay Yang; Shujun Liu; Takahiro Takano; Xiaohai Wang; Qun Gao; Klaus Willecke; Maiken Nedergaard
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

4.  Gap junction-mediated transfer of miR-145-5p from microvascular endothelial cells to colon cancer cells inhibits angiogenesis.

Authors:  Dominique Thuringer; Gaetan Jego; Kevin Berthenet; Arlette Hammann; Eric Solary; Carmen Garrido
Journal:  Oncotarget       Date:  2016-05-10

5.  Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.

Authors:  Jianyong Xiao; Guangxian Zhang; Bin Li; Yingya Wu; Xijuan Liu; Yuhui Tan; Biaoyan Du
Journal:  Oncotarget       Date:  2017-01-03

6.  Bioavailability and efficacy of a gap junction enhancer (PQ7) in a mouse mammary tumor model.

Authors:  Stephanie N Shishido; Keshar Prasain; Amanda Beck; Thi D T Nguyen; Duy H Hua; Thu Annelise Nguyen
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

7.  Tanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communication.

Authors:  Jianyong Xiao; Guangxian Zhang; Pengxiang Qiu; Xijuan Liu; Yingya Wu; Biaoyan Du; Jiefen Li; Jing Zhou; Jingjing Li; Yuhui Tan
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

Review 8.  Adrenocortical Gap Junctions and Their Functions.

Authors:  Cheryl L Bell; Sandra A Murray
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-29       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.